News

The products will be distributed under BioGaia’s own brand through the retail pharmacy channel in the region. BioGaia chief executive officer Peter Rothschild said, "We are pleased with

The new online system available on gsk.com enables researchers to access the detailed trial data that helps with more scientific understanding and patient care improvement. Researchers should provide

Relasv is the diagnostic test developed by Corgenix and members of the Viral Hemorrhagic Fever Consortium (VHFC), a collaboration of academic and industry members headed by Tulane University

Nutrition Zone CEO Pete De Anda said, "I’m delighted to have Vita Cell and Max Plus in our Nutrition Zone stores. I have been on the Vita Cell

TINA molecules placed at the 5′ end of primers, stabilize duplex formation. The intercalators have high sensitivity and specificity of endpoint and PCR. QuantiBact managing director and CEO

KSCP will become a wholly-owned subsidiary of Sagent on the completion of the acquisition. Sagent CEO and chairman Jeffrey Yordon said that its partnership with Kanghong was instrumental

The glatiramer acetate depot formulation is to be injected once-a-month under the skin or into a muscle for a prolonged release of the therapeutic agent. Mapi Pharma president

Alimera Sciences, pSivida’s licensee, has reported the treatment of first patient following the commercial launch in the region. pSivida president and chief executive officer Dr. Paul Ashton said

Sativex is indicated for the treatment of moderate to severe spasticity in multiple sclerosis (MS) in patients who showed inadequate response to other anti-spasticity medications. GW chief executive